Ambrx Funding & Investors
Ambrx, Inc. operates as a biopharmaceutical company. The Company develops therapeutics such as long acting proteins, bi-specifics, and antibody drug conjugates. Ambrx operates in worldwide.
ambrx.comTotal Amount Raised: $500,948,992
Ambrx Funding Rounds
Post Ipo Equity
$75,000,000
Post Ipo Equity
$78,000,000
Private Equity
$200,000,000
Private Equity Investors
HBM Healthcare InvestmentsInvus GroupSuvretta Capital ManagementAdage Capital ManagementCormorant Asset ManagementFidelity Management and Research CompanyBlackRockSeries Unknown
$45,000,000
Series Unknown Investors
Hopu Investment Management CoNortheast SecuritiesEverbrightApricot CapitalSinopharm HoldingPost Ipo Equity
$75,000,000
Post Ipo Equity
$78,000,000
Private Equity
$200,000,000
Private Equity Investors
HBM Healthcare InvestmentsInvus GroupSuvretta Capital ManagementAdage Capital ManagementCormorant Asset ManagementFidelity Management and Research CompanyBlackRockSeries Unknown
$45,000,000
Series Unknown Investors
Hopu Investment Management CoNortheast SecuritiesEverbrightApricot CapitalSinopharm HoldingSeries D
$10,000,000
Series D Investors
AravisM VenturesVersant VenturesTavistock Group5am VenturesCMEA CapitalMaverick VenturesSeries D
$10,000,000
Series D Investors
AravisM VenturesVersant VenturesTavistock Group5am VenturesCMEA CapitalMaverick VenturesSeries C
$52,000,000
Series C Investors
AravisVersant VenturesTavistock Group5am VenturesCMEA CapitalRoche Venture FundApposite CapitalMaverick VenturesSeries C
$52,000,000
Series C Investors
AravisVersant VenturesTavistock Group5am VenturesCMEA CapitalRoche Venture FundApposite CapitalMaverick VenturesSeries B
$5,000,000
Series B Investors
Versant VenturesTavistock Group5am VenturesSeries B
$5,000,000
Series B Investors
Versant VenturesTavistock Group5am VenturesSeries A
$23,449,000
Series A Investors
Versant VenturesTavistock Group5am VenturesMaverick VenturesSeries A
$23,449,000
Series A Investors
Versant VenturesTavistock Group5am VenturesMaverick VenturesSeries A
$12,500,000
Series A Investors
Tavistock Group5am VenturesSeries A
$12,500,000
Series A Investors
Tavistock Group5am Ventures
Funding info provided by Diffbot.